StockData
Pacira BioSciences, Inc. logo

Pacira BioSciences, Inc. (PCRX) stock

PCRXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 6/3034% above fair value
$36.34+0.00 (0.00%)

Close on Oct 19, 2026Market cap $1.45BP/E 103.8Yield –

Pacira BioSciences pe ratio

The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.

Pacira BioSciences's pe ratio was 104.2× on Nov 11, 2026, against 51.2× a year earlier. Over the last 5 years it ranged from 10.9× to 258.2×, with a median of 66.5×.

PE Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 2026104.2×+47.9
2025Dec 31, 202556.3×+44.2
2024Oct 31, 202412.0×−212.3
2023Dec 29, 2023224.3×+132.4
2022Dec 30, 202291.9×+47.7
2021Dec 31, 202144.2×+23.2
2020Dec 31, 202021.1×−217.1
2019Oct 31, 2019238.2×–

More Pacira BioSciences figures

See a number that looks wrong?